UK BREXIT – eCTD BASELINE for Converting CAPs into UK MAs

The North Face The North Face 20ss Scoop Jacket NP61940 KW Black White L from Stylish Anglers

9 October 2020

BlueReg

From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be the UK’s stand-alone medicines and medical devices regulator.

 

In this context MHRA has released the following guidance – “Converting Centrally Authorised Products (CAPs) to UK Marketing Authorisations (MAs) from 1 January 2021, 'grandfathering' and managing lifecycle changes” focused on:

BlueReg Support

 

In this context, BlueReg has already worked on the guidance and set up the support and solutions so that its clients can convert their procedures from centralized procedures to National MAs while limiting the impact on their business as much as possible.

 

Thus, BlueReg can help you on:

 

 

BlueReg

Did you like this article? Share on social networks:

Associated News

The French system for preventing and managing shortages

The French regulation on the prevention and management of stock shortages of medicinal products is...

Learn more

Season’s greetings and Happy New Year 2021 !

❄ Season’s greetings and Happy New Year !   This year BlueReg is proud to...

Learn more

Consulting Regulatory Affairs Services for Pharmaceutical companies

  The regulatory affairs process is a critical component of the safe development, registration and...

Learn more


Line - Organism